Toll-like receptor signaling pathway variants and prostate cancer mortality.

  title={Toll-like receptor signaling pathway variants and prostate cancer mortality.},
  author={Jennifer Rider Stark and Fredrik Wiklund and Henrik Gr{\"o}nberg and Fredrick Schumacher and Jennifer A Sinnott and Meir Jonathan Stampfer and Lorelei A. Mucci and Peter Kraft},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  volume={18 6},
An understanding of factors associated with prostate cancer (PCa) mortality is increasingly important given the biological heterogeneity of disease. Previous studies have shown that genetic variation in the Toll-like receptor (TLR) signaling pathway is associated with PCa incidence, but any role in progression and mortality is unclear. Among 1,252 PCa cases… CONTINUE READING